agrid automated glucose reading insulin dispenser svijayak/mainpagecs410.html...
TRANSCRIPT
AGRIDAGRIDAutomated Glucose Reading Insulin DispenserAutomated Glucose Reading Insulin Dispenser
www.cs.odu.edu/~svijayak/MainPageCS410.html
Presented by T. GatdulaCo-presenters S.
Vijayakumar D. Yang
Problem StatementProblem Statement
Diabetics do not follow their prescribed insulin regimen.
AgendaAgendaSocietal problem Problem statementProject goalComponent requirementsBenefitsObstaclesRisks & MitigatorsPreliminary budgetProjected scheduleManagement methodsResource requirements
American Diabetes Statistics
16 million cases of diabetes2,500 new cases daily7th leading cause of death193,140 deaths in 1996 $44 billion in direct medical costs
*Statistics from ADA & NIDDK
Diabetes Management Diabetes Management SurveySurvey
2/3 find regimen difficult to manage41% “unsuccessful” at management3 in 5 do not monitor as prescribed17% do not maintain insulin regimen1 in 5 find regimen restricting
*Survey by Eli Lilly company
Survey- DiabeticsSurvey- DiabeticsDiabetics Vs. Non Diabetics
1 8 %
8 2 %
Diabetics
Non Diabetics
Diabetic Types
56%
44%Type 1
Type 2
Type 1 Classification
29%
7%
14%
43%
7%
15 Years or less
16-25Years
26-35 Years
36-45 Years
46-55 Years
Type 2 Classification12%
6%
41%
29%
12%
15 Years or less
16-25Years
26-35 Years
36-45 Years
46-55 Years
Survey- Monitoring
Blood Monitoring - Type1 & Type 2
42%
35%
19%
4%
None
Once
Twice
More than threetimes
Problem StatementProblem Statement
Diabetics do not follow their prescribed insulin regimen.
Project GoalProject Goal
Given a simplified insulin protocol, insulin-dependent diabetics will be more likely to maintain their prescribed insulin regimen.
Existing Monitoring Existing Monitoring DevicesDevices
Product
Cost Accuracy
Issues Accessories
Glucose Monitor
$890/ annually
98-99% Invasive, Calluses
Strips, Lancets
Glucose Watch
$260 100% Itchiness in area
Batteries
Existing Dispensing Devices
Product Cost Accuracy
Issues Accessories
Insulin Pen
$35 99% Intrusive, Precision
Needles
Syringe $23/100
100% Intrusive, Precision
Disposal System
Insulin Pump
$4,000 98.6% Intrusive, Complex
Needles, Tubing
Medication
Varies Varies Regimented
N/A
Insulin Patch
~$3.20 Not Released
Final Testing Phase
N/A
Component RequirementsComponent Requirements
1 26
5438 9 07
Enter
Blinker 100
InputUltra Sound
AGRIDPatch
Functional Diagram
User Info Monitor
Warning
Ultra Sound
Warning
High
ComputationalDevice
Low
Within Range
Patch
What AGRID Will Do
Glucose monitoring Virtually non-invasiveContinuous
Insulin dispensingNon-invasiveContinuous
What AGRID Will Not Do
Not a cure for diabetesNot for those with minimal diabetes
Project Objectives
ResearchBudget/cost projectionSBIR grant proposalAcquisition of materialsBuilding of prototypeValidate product
AGRID Company StructureAGRID Company Structure
ObstaclesObstacles
Government approvalSide effectsSocietal reluctance
BenefitsBenefits
All-in-oneConvenientNon-invasiveUnobtrusivePeace of mind
Risks and MitigatorsRisks and Mitigators
Diabetes cured Very far into the future
Simpler regimentation becomes available
Our solution is simple
Unable to acquire government approval
Alter product to meet requirements
Unit not covered by insurance
Reduce sales
Unable to attain user-rights
Find alternative devices
Budget- Initial Budget- Initial DevelopmentDevelopment
Licensing Glucowatch 20,000
Costs Insulin Patches 80,000
Ultrasound Device
50,000
Software Development
30,000
Development Costs
$180,000
Testing $200,000
TOTAL $380,000
Budget- ProductionBudget- ProductionUnit AGRID 500
Costs @ 200 units
$100,000
Operation Testing 2,000
Cost Maintenance
5,000
Computational Device
Research & Development
10,000
$17,000
TOTAL $117,000
Profit ProjectionsAGRID 500
Retail 550 50
@100,000 units
$5,000,000
Insulin Patch 3
Retail 3.10 .10
@365 annual
@ 100,000 units
$3,650,000
TOTAL $8,650,000
ScheduleConcept development- 3 months Prototype design- 5 monthsPre-production design- 6 monthsProduction- 36 months
Concept Development
Prototype Design
Pre-Production Design
Production
3 months 5 months 6 months 36 months
Conclusion
Societal needFinancially feasibleMarketableWithin time constraintsGreater quality of life
Research Siteswww.diabetes123.comwww.childrenwithdiabetes.comwww.nih.govwww.dcct.com www.glucowatch.comwww.sontra.comwww.niddk.nih.gov